🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
278 medicines starting with “Z”
MedicineActive substanceLicence holderStatus
Zofran Zydis 8 mg oral lyophilisate
PA0711/327/006
Ondansetron Rowex Limited, Marketed
Zoftacot 3.35 mg/ml eye drops, solution in single-dose container
PA1107/013/001
Hydrocortisone sodium phosphate Laboratoires Thea Marketed
Zokinvy 50 mg hard capsules
EU/1/22/1660/001
Lonafarnib TMC Pharma (EU) Limited
Zokinvy 75 mg hard capsules
EU/1/22/1660/002
Lonafarnib TMC Pharma (EU) Limited
Zoladex 3.6 mg implant
PA1019/027/001
Goserelin AstraZeneca AB Marketed
Zoladex 3.6 mg implant
PPA1463/125/001
Goserelin IMED Healthcare Ltd.,
Zoladex LA 10.8 mg implant
PA1019/027/002
Goserelin AstraZeneca AB Marketed
Zoladex LA 10.8 mg implant
PPA1463/125/002
Goserelin IMED Healthcare Ltd.,
Zoladex LA 10.8 mg Implant
PPA2306/027/001
Goserelin Originalis B.V.
Zoledronic acid 4 mg/5 ml concentrate for solution for infusion
PA2059/019/001
Zoledronic acid Fresenius Kabi Deutschland GmbH Not marketed
Zoledronic Acid 4 mg/5 ml Concentrate for solution for infusion
PA1122/016/001
Zoledronic acid Noridem Enterprises Limited Not marketed
Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion
EU/1/13/834/001-003
Zoledronic acid monohydrate Accord Healthcare S.L.U.
Zoledronic acid Actavis 4 mg/5 ml concentrate for solution for infusion
EU/1/12/759/001-003
Zoledronic acid monohydrate Actavis Group hf
Zoledronic Acid Hospira 4 mg/100 ml solution for infusion
EU/1/12/800/003
Zoledronic acid monohydrate Pfizer Europe MA EEIG
Zoledronic Acid Hospira 4 mg/5 ml concentrate for solution for infusion
EU/1/12/800/001-002
Zoledronic acid monohydrate Pfizer Europe MA EEIG
Zoledronic Acid Hospira 5 mg/100 ml solution for infusion
EU/1/12/800/004
Zoledronic acid monohydrate Pfizer Europe MA EEIG
Zoledronic acid medac 4 mg/100 ml solution for infusion
EU/1/12/779/004-006
Zoledronic acid monohydrate medac Gesellschaft für klinische Spezialpräparate mbH
Zoledronic acid Mylan 4 mg/5 ml concentrate for solution for infusion
EU/1/12/786/001-003
Zoledronic acid monohydrate Mylan Pharmaceuticals Limited
Zoledronic acid Seacross 5 mg solution for infusion
PA22766/010/001
Zoledronic acid monohydrate Seacross Pharma (Europe) Limited Marketed
Zoledronic Acid Teva 4 mg/5 ml concentrate for solution for infusion
EU/1/12/771/001-006
Zoledronic acid Teva Pharma B.V.
Zolgensma 2 x 1013 vector genomes/mL solution for infusion
EU/1/20/1443/001-0037
Onasemnogene Abeparvovec Novartis Europharm Limited
Zolmitriptan 2.5 mg Orodispersible Tablets
PA2315/232/001
Zolmitriptan Accord Healthcare Ireland Ltd. Marketed
Zolnod 10 mg film-coated tablets
PA0711/039/001
Zolpidem tartrate Rowex Limited, Marketed
Zolpidem Tartrate Teva 10 mg film-coated tablets
PA0749/095/002
Zolpidem tartrate Teva Pharma B.V. Marketed
Zolpidem Tartrate Teva 5 mg film-coated tablets
PA0749/095/001
Zolpidem tartrate Teva Pharma B.V. Marketed
ZOLSKETIL pegylated liposomal 2 mg/mL concentrate for dispersion for infusion
EU/1/22/1629/001-0004
Doxorubicin Hydrochloride, Liposomal Accord Healthcare S.L.U.
Zomarist
EU/1/08/483/7-18
Novartis Europharm Limited
Zomarist 50 mg/850 mg film-coated tablets
EU/1/08/483/1-6
Novartis Europharm Limited
Zomel 15 mg gastro-resistant capsule, hard
PA0126/147/001
Lansoprazole Clonmel Healthcare Ltd Marketed
Zomel 30 mg gastro-resistant capsule, hard
PA0126/147/002
Lansoprazole Clonmel Healthcare Ltd Marketed
Zometa
EU/1/01/176/004
Zoledronic acid Phoenix Labs
Zometa 4 mg powder and solvent for solution for infusion
EU/1/01/176/001
Zoledronic acid Phoenix Labs
Zometa 4 mg powder and solvent for solution for infusion
EU/1/01/176/002
Zoledronic acid Phoenix Labs
Zometa 4 mg powder and solvent for solution for infusion
EU/1/01/176/003
Zoledronic acid Phoenix Labs
Zometa 4 mg/100 ml solution for infusion
EU/1/01/176/007-009
Zoledronic acid monohydrate Phoenix Labs
Zomig 2.5 mg tablets
PPA0465/099/001
Zolmitriptan PCO Manufacturing Ltd.
Zomig 2.5 mg Tablets
PA2242/004/001
Zolmitriptan Grunenthal Pharma Ltd Marketed
Zomig 2.5 mg Tablets
PPA1463/168/001
Zolmitriptan IMED Healthcare Ltd.,
Zomig Rapimelt 2.5 mg orodispersible Tablets
PA2242/004/002
Zolmitriptan Grunenthal Pharma Limited. Marketed
Zomig Rapimelt 2.5 mg orodispersible Tablets
PPA1463/168/002
Zolmitriptan IMED Healthcare Ltd.,
Zomig Rapimelt 2.5 mg Orodispersible Tablets
PPA0465/099/002
Zolmitriptan PCO Manufacturing Ltd.
Zonegran 100 mg hard capsules
EU/1/04/307/004
Zonisamide Amdipharm Limited
Zonegran 25 mg hard capsules
EU/1/04/307/001
Zonisamide Amdipharm Limited
Zonegran 50 mg hard capsules
EU/1/04/307/003
Zonisamide Amdipharm Limited
Zonisamide Desitin 20 mg/ml oral suspension
PA0815/007/001
Zonisamide Desitin Arzneimittel GmbH Not marketed
Zonisamide Rowex 100 mg hard capsules
PA0711/336/003
Zonisamide Rowex Limited, Not marketed
Zonisamide Rowex 25 mg hard capsules
PA0711/336/001
Zonisamide Rowex Limited, Not marketed
Zonisamide Rowex 50 mg hard capsules
PA0711/336/002
Zonisamide Rowex Limited, Not marketed
Zonisamide Viatris 100 mg hard capsules
EU/1/16/1093/009-013
Zonisamide Viatris Limited
Zonisamide Viatris 25 mg hard capsules
EU/1/16/1093/001-004
Zonisamide Viatris Limited
1 2 3 4 5 6
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.